As of today (2025-06-28), AnaptysBio's share price is $22.45. AnaptysBio's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was $1.12. Hence, AnaptysBio's Price to Tangible Book Ratio of today is 20.04.
The historical rank and industry rank for AnaptysBio's Price-to-Tangible-Book or its related term are showing as below:
ANAB'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.96 Med: 3.53 Max: 69.61
Current: 20.04
During the past 12 years, AnaptysBio's highest Price to Tangible Book Ratio was 69.61. The lowest was 0.96. And the median was 3.53.
ANAB's Price-to-Tangible-Book is ranked worse than 92.33% of 1199
companies
in the Biotechnology industry
Industry Median: 2.86
vs ANAB: 20.04
The historical data trend for AnaptysBio's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AnaptysBio's Price-to-Tangible-Book
For the Biotechnology subindustry, AnaptysBio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AnaptysBio's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AnaptysBio's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where AnaptysBio's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
AnaptysBio Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of AnaptysBio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ANAB has been successfully added to your 